Robert Wellman, MS

Wellman_Robert_D_205x293.jpg

“Being part of Kaiser Permanente research teams gives me a chance to develop cutting-edge biostatistical methods while contributing to health care research with a national impact.”

Robert Wellman, MS

Biostatistician III, Kaiser Permanente Washington Health Research Institute

Biography

A graduate of the University of Washington (UW) biostatistics program, Robert Wellman, MS, joined the Kaiser Permanente Washington Health Research Institute (KPWHRI) Biostatistics Unit in 2009. His work spans a diverse collection of topics including mental health, pharmacoepidemiology, postmarketing drug safety surveillance, obesity, diagnostic test accuracy, back pain, and breast cancer. Prior to this, he spent 5 years in the Biostatistics Core at the UW Center for AIDS Research.

Research interests and experience

  • Biostatistics

    Causal inference; longitudinal data; diagnostic and screening test accuracy; clinical trials; survival analysis: rare disease outcomes; nonparametrics; missing data; electronic data; distributed data; statistical computing

    Vaccines & Infectious Diseases

    Biostatistics; HIV/AIDS; vaccine safety

    Complementary & Integrative Health

    Biostatistics; clinical trials; back pain

    Obesity

    Biostatistics; bariatric surgery

  • Cancer

    Biostatistics; breast cancer; effects of chemotherapy; accuracy of automated data; screening test accuracy; advanced imaging

    Medication Use & Patient Safety

    Biostatistics; pharmacoepidemiology; postmarketing drug safety surveillance; big data; electronic health record and claims data

    Mental Health

    Biostatistics; suicide risk prediction, machine learning

  •  
  •  

Recent publications

Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, Magid D, Wagner EH, for the Pharmacovigilance Study Team. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305. PubMed

Arterburn D, Wellman R, Westbrook E, Rutter C, Ross T, McCulloch D, Handley M, Jung C. Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs. Health Aff (Millwood). 2012;31(9):2094-104. PubMed

Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ; for the Pharmacovigilance Research Group. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May;52(5):e30-8. doi: 10.1097/MLR.0b013e31825a8c22. Epub 2012 May 25. PubMed

Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):673-80. Epub 2012 Feb 15. PubMed

Stekler JD, Wellman R, Holte S, Maenza J, Stevens CE, Corey L, Collier AC. Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group. Int J STD AIDS. 2012;23(3):201-6. PubMed

 

healthy findings blog

Video-screen_grab-bariatric-young_couple-_1_column.jpg

Best weight-loss surgery for diabetes and severe obesity?

Watch video on latest results from PCORnet Bariatric Study. (Spoiler alert: Bypass, not sleeve.)

news

Bariatric-Surgery-Patient-Doctor-visit_1col.jpg

How does gastric bypass compare with gastric sleeve?

Dr. David Arterburn and colleagues publish a large, long-term analysis of post-op safety of weight-loss surgeries.